/PRNewswire/ Dragon Master Initiative announces that it has reached ten years as a 501(c)3 nonprofit charitable organization that champions cures for kids.
/PRNewswire/ Dragon Master Initiative today announced that its founder and president Amanda Haddock has joined the National Institutes of Health (NIH).
Win Great Prizes and Raise Money to Fund Cancer Research for Kids.
Hundreds, possibly thousands of dragons will race the Lazy River at Rock River Rapids in Derby on Sunday August 8th! Each dragon will be individually numbered.
Purchase your entries, and you will be randomly assigned a dragon. If it wins, you win! First duck across the finish line wins $1000 cash!
Prices vary from $10 for one dragon entry to as low as $5 each when you buy thirty. Entries may be purchased up until Midnight on Friday 8/6/2021. What are you waiting for? Go to the top of the page to purchase entries, event tickets, or to donate to the cause!
Facing death, Kansas student goes to Super Bowl, inspiring a team of players, parents Eric Adler, The Kansas City Star
Feb. 7 If on Sunday evening, you are like millions of others who will be looking to the Super Bowl to witness moments of nearly unimaginable grit and grace, courage in the face of overwhelming pressure, you can certainly look to the field.
Or you can look up into the stadium: section 238, row E.
That s where Jace Ward of Wamego, Kansas, will be sitting with his dad.
He will be the one in a Patrick Mahomes jersey, blond, soon to turn 22, a senior at Kansas State University cheering from the seats given to him by Kansas City Chiefs fullback Anthony Sherman.
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
January 08, 2021 06:00 ET | Source: Chimerix, Inc. Chimerix, Inc.
ONC201 Registrational Trial for Recurrent H3 K27M-mutant Glioma
Compelling Response Rates to Date; Defined Regulatory Path to Registration Pivotal Data Anticipated in 2021 to Support Potential Registration, Addressing an Estimated Market Opportunity of Greater than $500 Million
Management to Host Conference Call at 8:30 a.m. ET Today
DURHAM, N.C., Jan. 08, 2021 (GLOBE NEWSWIRE) Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that the Company has acquired Oncoceutics, Inc., a privately-held, clinical-stage biotechnology company developing imipridones, a novel class of compounds. Oncoceutics’ lead product candidate, ONC201, has been shown in clinical testing to selectively induce c